Jade Biosciences expands CFO Brad Dahms' role to include chief business officer
JBIO•Jade Biosciences added the chief business officer title to CFO Brad Dahms' role. He will lead business development and corporate strategy as the pipeline advances toward multiple clinical readouts in 2027.
1. Expanded responsibilities
Jade Biosciences expanded Chief Financial Officer Brad Dahms' role to include chief business officer. Dahms will lead business development and corporate strategy as the pipeline advances toward multiple clinical readouts in 2027.
